GileadGilead WHO mistakenly posted study results that appeared to show that a leading potential coronavirus treatment failed to help patients www.businessinsider.myby thefundedfx7
GILD may be taking off soon from hereShort term price target $86 Mid term price target $100 Long term price target $125 Stop Loss at $84Long10:08by davidhaiyangzou1110
GILD range bound, unlikely to break-outNASDAQ:GILD Remdesivir may help GILD breakout from multi-year range-bound pattern, however giving the limited income from it in the short-term, I would reckon we don't break out.by Fundamentals5003
Can the New FDA Nod of Approval Push Gilead to New Highs U.S. FDA approved Gilead Sciences Inc.’s experimental antiviral drug, remdesivir, for use as it’s showing good signs of helping hospitalised patients recover more quickly from Corona Virus. From a Trend Analysis perspective - price action has been very choppy with lots of buying and selling in an almost Up-trending consolidation. We expect Gilead to push higher with this recent news coupled with it Beating Earning Expectations for Q1 2020. This stock isnt a value stock with a PE of 18x and a Price to Book of 4x but it isn't overly expensive considering its growth potential (PEG 5yr 0.57). Longby Tuhi_Capital5
GILD FDA APPROVAL President Trump announced in the last 5 minutes that GILD's (Remdesivir) was FDA approved for the treatment of Covid-19 by The_OnlyRule227
GILD Analysis ||| it's a short term buy (2-5 months)The GILD price fold into the inside pitchork channel on the long term. This signal a long term downtrend, which does not serve visionary long term investment. However, for the intermediate term analysis. GILD price follow channel patter as is in the second channel. Despite the extraordinary selling volume, the price found a strong support at 75$. GILD next TP needs to be positioned at 89$. If the price breaks the 89$ resistance with momentum, the next TP is at 103$. Longby UTOMAN6
Gilead Sciences LongA medical tech company know for different drugs but currently it is making Remdesivir. In studies it shows it helps covid-19 recovery. Based on breaking and closing above resistance today we would go back to 110Longby Betguardian4
GILEAD VS COVID-19NYT: FDA PERMISSION FOR GILEAD AGAINST COVID-19 IN EMERGENCIES MAY BE ANNOUNCED ALREADY TODAY Buy now Sell levels on the chart Profit +250-400 % Wish you luck !Longby Citdl4412
Hold My Beer Award for the Quarter - You, Sir, are Drunk.Technical Indicators, Wave Analysis? by BeenBambied8
Top 3 Stocks NOW 🚀| April 2020😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Stocks : GILD NASDAQ:GILD What’s the Strategy here : GILD . The company has announced of their drugs and the highest spec ability and then some scandals appeared that the drugs don't treat the disease which led to the stock to fill downhill From $83 to $75 . And after that we can see some kind of Recovery when the company announced that it was misinformation and it doesn't relate to the drugs treatment . And now they are in the process of releasing a new drug, basically we do not care if the drug will be successful or not we care about how the stock will react to the news , and we have a high chance for the stock due to the company's spikeability in the past . How can you actually use this ? We ONLY trade regarding the news ! Meaning that when we see the anticipatory run UP I start trading it and letting my students and followers take the advantage 👨🎓. The Best Part You can follow me and apply my trades for FREE !!! QUESTIONS ? Please comment below , what you have in mind 😊Longby UnknownUnicorn68771776611
Gild needs to clear 82-84 areaI like it holding the dash line. The more it tests and holds, the power it accumulates. Longby Dllew20194
$GILD - Please read the text below"Related: Yesterday, the WHO mistakenly posted draft documents of a Chinese study that showed remdesivir failed to improve patients' conditions. Gilead countered that the study was underpowered for efficience since it was terminated early for low enrollment." I'm not holding the stock. Just had the feeling to post it! Technically the stock remain strong! Good-luck to all.by Samuel12_19806
Gilead in tested channelGILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir. Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance. A close below the 50sma would change the sentiment, and remove us from the channel. Longby dorfmanmaster116
GILEAD Short Term Uptrend Trade PlanTrade Plan for Gilead Sciences. Will look to enter at bottom of uptrend channel (75.3) , Stop Loss once uptrend broken (74). Target Price at 86. Potential Price at 96. Personally will take profit at resistances as insurance. Upside for Gilead: 1a) Possible treatment for Covid-19 (Remdesivir) 1b) Possible 2nd wave of virus 2) Possible FDA approval of Arthritis drug Downside for Gilead: 1) Leaked report of Remdesivir failing in China randomized trial, which was cancelled early due to low enrollment numbers. Bears clinging on hopes that the conclusion was inaccurate due to short duration of studyLongby DicksonChong116
$GILD Holds Bullish Posture as Key Data Looms for Top TreatmentGILD is the leader on the treatment side of the game with its remdesivir asset. The market will likely react to every new development. But the chart is very constructive at this point. However, everything will depend on new data from trials now underway around the world.by GregFolin227
Mainstream media has trashed Chloroquine and sold GileadThe new drug by Gilead will make certain people filthy richLongby Crypto_Curry116
GILD just watch the boxInside the box my bias is short. Above the box my bias is long. Targets = dotted black lines. Beware massive news risk with this name. It can explode in the either direction on one tweet.by WadeYendall13
GILD Looking for a Long Entry After the Gap UpSUMMARY: Looking for a long entry on Gilead Sciences (GILD) after the gap up on news of a COVID treatment. HEADLINE: Looking for a Long Entry After the Gap Up TICKER: GILD STRATEGY USED: Silver Scalper Trend Confirmation = Range MA Entry Signal = Bull/Bear Power Exit Signal = Bull/Bear Power OR Range MA --- DESCRIPTION: 1. With this strategy we enter long on Bull signals and exit on Bear signals when the trend is bullish. 2. The current trend on GILD is bullish according to our Alpha RMA (Green bar color). 3. We are currently looking for a Bull signal for a long entry. 4. We expect a stop and go off of S1 to get our long entry. 5. If we get the long entry at S1 we will be looking at R1 to see how the price reacts. 6. If S1 can't hold we will watching for a Bull signal in the S2 range. --- NOTE: We conduct market analysis on a daily basis from a trend trading perspective using our own in house built tools. If you like any of the content we provide please leave a like and a follow to show your appreciation.by AlphaBotSystem8